Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

NCT01960634 is registered in ClinicalTrials.gov with Grupo Español Multidisciplinar de Melanoma as lead sponsor.

NCT NCT01960634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Lead sponsor
Grupo Español Multidisciplinar de Melanoma
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
May 31, 2015
Enrollment
58 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv skin melanoma